切换至 "中华医学电子期刊资源库"

中华脑科疾病与康复杂志(电子版) ›› 2019, Vol. 09 ›› Issue (01) : 30 -35. doi: 10.3877/cma.j.issn.2095-123X.2019.01.007

所属专题: 文献

临床研究

早期与延迟介入治疗对颅内破裂动脉瘤患者的疗效和DCI发生率的差异
李传玉1, 黄海能1, 黄华东1, 符黄德1, 罗起胜1, 罗琨祥1, 覃成箭1, 栗学玉1, 郑传华1, 蓝川琉1, 贺献贵2, 王向宇3,()   
  1. 1. 533000 广西百色,右江民族医学院附属医院神经外科
    2. 552300 贵州望谟,望谟县人民医院神经外科
    3. 510000 广州,暨南大学附属第一医院神经外科
  • 收稿日期:2018-12-18 出版日期:2019-02-15
  • 通信作者: 王向宇

Differences of efficacy and the incidence of DCI between early and delayed interventional therapy in patients with intracranial ruptured aneurysms

Chuanyu Li1, Haineng Huang1, Huadong Huang1, Huangde Fu1, Qisheng Luo1, Kunxiang Luo1, Chengjian Qin1, Xueyu Li1, Chuanhua Zheng1, Chuanliu Lan1, Xiangui He2, Xiangyu Wang3,()   

  1. 1. Department of Neurosurgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, China
    2. Department of Neurosurgery, Guizhou Wangmo County People’s Hospital, Wangmo County 552300, Guizhou Province, China
    3. Department of Neurosurgery, The First Affiliated Hospital of Ji’nan University, Guangzhou 510000, China
  • Received:2018-12-18 Published:2019-02-15
  • Corresponding author: Xiangyu Wang
  • About author:
    Corresponding author: Wang Xiangyu, Email:
引用本文:

李传玉, 黄海能, 黄华东, 符黄德, 罗起胜, 罗琨祥, 覃成箭, 栗学玉, 郑传华, 蓝川琉, 贺献贵, 王向宇. 早期与延迟介入治疗对颅内破裂动脉瘤患者的疗效和DCI发生率的差异[J/OL]. 中华脑科疾病与康复杂志(电子版), 2019, 09(01): 30-35.

Chuanyu Li, Haineng Huang, Huadong Huang, Huangde Fu, Qisheng Luo, Kunxiang Luo, Chengjian Qin, Xueyu Li, Chuanhua Zheng, Chuanliu Lan, Xiangui He, Xiangyu Wang. Differences of efficacy and the incidence of DCI between early and delayed interventional therapy in patients with intracranial ruptured aneurysms[J/OL]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2019, 09(01): 30-35.

目的

探讨不同介入治疗时机对颅内破裂动脉瘤患者的疗效及迟发性脑缺血(DCI)发生率的影响,并分析导致术后DCI发生的危险因素。

方法

回顾性分析自2014年1月至2018年6月于右江民族医学院附属医院神经外科行介入治疗的颅内破裂动脉瘤患者98例的临床资料,按照介入手术的时机将所有患者资料分为早期组(n=57)和延迟组(n=41)。其中所有患者均在常规治疗的基础上行介入治疗,其中早期组介入时间在发病后72 h内,而延迟组介入时间超过发病后72 h。比较2组患者治疗效果,术后并发症及预后情况之间的差异,并对导致患者术后DCI的危险因素进行单因素及多因素Logistic分析。

结果

2组患者治疗后2周时NIHSS评分之间差异无统计学意义(6.27±2.19 vs 5.76±1.94,P>0.05),早期组完全栓塞率显著高于延迟组(91.23% vs 73.17%,P<0.05),2组患者术后DCI、CVS、再破裂出血、脑水肿及下肢静脉栓塞发生率差异无统计学意义(P>0.05),早期组随访3个月时预后良好率及巴塞尔指数评分显著高于延迟组[80.70% vs 70.73%,(63.51±13.42)vs (52.78±12.65),P<0.05],本次研究中患者治疗后DCI发生率为12.44%,低蛋白血症、Fisher分级Ⅲ~Ⅳ及WFNS分级Ⅲ~Ⅴ级是DCI发生的独立危险因素(OR=4.29、5.48、8.074,P<0.05)。

结论

早期介入能提升栓塞效果的同时有效改善患者预后,低蛋白血症、Fisher分级Ⅲ~Ⅳ及WFNS分级Ⅲ~Ⅴ级是颅内动脉瘤介入术后发生DCI的独立危险因素。

Objective

To investigate the differences of efficacy and the incidence of delayed cerebral ischemia (DCI) between early and delayed interventional therapy in patients with intracranial ruptured aneurysms, and the risk factors leading to postoperative DCI.

Methods

The clinical data of 98 patients with intracranial ruptured aneurysm who underwent interventional therapy in our hospital from January 2014 to February 2018 were retrospectively analyzed. The patients were divided into early group (n=57) and delayed group (n=41) according to the timing of interventional surgery. All of the patients underwent interventional therapy based on conventional therapy. The early intervention time was within 72 h after the onset, while the delayed intervention time was more than 72 h after the onset. The differences in treatment outcomes, postoperative complications, and prognosis between the two groups were compared, and the multivariate logistic analyses were performed on the risk factors for postoperative DCI.

Results

There was no significant difference in the NIHSS scores between the two groups at 7 d after treatment (6.27±2.19 vs 5.76±1.94, P>0.05). The complete embolization rate was significantly higher in the early group than in the delayed group (91.23% vs 73.17%, P<0.05). There was no significant difference in the incidence of postoperative DCI, CVS, rupture in hemorrhage, cerebral edema and lower extremity venous thrombosis between the two groups (P>0.05). The prognosis rate and Barthel index score were significantly higher in the early group at 3 months than in the delayed group (80.70% vs 70.73%, 63.51±13.42 vs 52.78±12.65, P<0.05). The incidence of DCI after treatment in this study was 12.44%. Hypoproteinemia, Fisher grade (Ⅲ-Ⅳ), and WFNS grade (Ⅲ-Ⅴ) were independent risk factors for DCI (OR=4.29, 5.48, 8.074, all P<0.05).

Conclusion

Interventional therapy is relatively effective in the treatment of patients with intracranial ruptured aneurysms, but early intervention can improve the embolization effect and improve the prognosis of patients, but the effect of postoperative DCI is not significant, leading to postoperative DCI. Hypoproteinemia, Fisher classification (Ⅲ-Ⅳ) and WFNS grade (Ⅲ-Ⅴ) are independent risk factors.

表1 2组患者基线资料比较
表2 2组患者治疗效果比较(Mean±SD)
表3 2组患者术后并发症情况比较[例(%)]
表4 2组患者随访3个月时预后情况比较
表5 导致患者术后DCI发生的单因素分析结果[例(%)]
表6 导致患者术后DCI发生的多因素Logistic分析结果
[1]
Okazaki T, Kuroda Y. Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome[J]. J Intensive Care, 2018, 6: 28.
[2]
Chalouhi N, Bovenzi CD, Thakkar V, et al. Long-term catheter angiography after aneurysm coil therapy: results of 209 patients and predictors of delayed recurrence and retreatment[J]. J Neurosurg, 2014, 121(5): 1102-1106.
[3]
叶华卫,宋彧,江先福,等.颅内微小动脉瘤破裂出血急性期血管内单纯栓塞治疗研究[J].中华神经医学杂志, 2016, 15(8): 814-818.
[4]
Weidauer S, Lanfermann H, Raabe A, et al. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage a prospective MRI and DSA study[J]. Stroke, 2007, 38(6): 1831-1836.
[5]
刘景鹏,叶振南,张翔圣,等.动脉瘤性蛛网膜下腔出血后迟发性脑缺血的危险因素分析[J].中国脑血管病杂志, 2017, 14(1): 10-14.
[6]
国家卫生计生委脑卒中防治工程编写委员.中国动脉瘤性蛛网膜下腔出血诊疗指导规范[J].中国脑血管病杂志, 2016, 13(7): 384-392.
[7]
中华医学会神经外科学分会神经介入学组.颅内动脉瘤血管内介入治疗中国专家共识(2013)[J].中华医学杂志, 2013, 93(39): 3093-3103.
[8]
郑匡,田作富,谭显西,等.早期治疗高分级动脉瘤性蛛网膜下腔出血的一年预后因素多中心研究[J].中华外科杂志, 2016, 54(7): 534-539.
[9]
Duffy L, Gajree S, Langhorne P, et al. Reliability (inter-rater agreement) of the Barthel index for assessment of stroke survivors systematic review and meta-analysis[J]. Stroke, 2013, 44(2): 462-468.
[10]
Greenberg ED, Gobin YP, Riina H, et al. Role of CT perfusion imaging in the diagnosis and treatment of vasospasm[J]. Imaging Med, 2011, 3(3): 287-297.
[11]
Greenberg ED, Gold R, Reichman M, et al. Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a Meta-analysis[J]. AJNR Am J Neuroradiol, 2010, 31(10): 1853-1860.
[12]
王洋,白如林.颅内动脉瘤治疗方法的选择及研究进展[J].中华神经医学杂志, 2010, 9(12): 1294-1296.
[13]
章雁,杨晓明.介入治疗时机对Hunt-Hess高分级颅内动脉瘤破裂治疗效果的影响[J].中华放射学杂志, 2014, 17(6): 492-495.
[14]
夏鹏飞,王伟,高旭婷,等.颅内未破裂动脉瘤介入术后脑缺血性损伤的危险因素分析[J].重庆医科大学学报, 2018, 43(2): 202-205.
[15]
Pegoli M, Mandrekar J, Rabinstein AA, et al. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage[J]. J Neurosurg, 2015, 122(2): 414.
[16]
Hockel K, Diedler J, Steiner J, et al. Long-term, continuous intra-arterial nimodipine treatment of severe vasospasm after aneurysmal subarachnoid hemorrhage[J]. World Neurosurg, 2016, 88: 104-112.
[17]
Behrouz R, Godoy DA, Topel CH, et al. Early hypoalbuminemia is an independent predictor of mortality in aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2016, 25(2): 230-236.
[18]
冯金福,段传志,李西锋,等.蛛网膜下腔出血患者迟发性脑血管痉挛相关因素的临床分析[J].中华神经医学杂志, 2009, 8(5): 509-512.
[19]
Veldeman M, Höllig A, Clusmann H, et al. Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review[J]. Br J Anaesth, 2016, 117(1): 17-40.
[20]
Takahashi Y, Sasahara A, Yamazaki K, et al. Disturbance of CT perfusion within 24 h after onset is associated with WFNS grade but not development of DCI in patients with aneurysmal SAH[J]. Acta Neurochir (Wien), 2017, 159(12): 2319-2324.
[21]
马修尧,王荣,任超,等.动脉瘤性蛛网膜下腔出血后迟发性脑缺血的危险因素及预后研究[J].中国现代医学杂志, 2017, 27(26): 114-118.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 511-516.
[2] 王友芳, 李兴超, 刘清敏, 刘德彬, 刘松伍, 郭冬冬, 车峰远. 应激性高血糖指数对经皮冠状动脉介入术后急性心肌梗死患者发生主要不良心脑血管事件的预测价值[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(02): 124-129.
[3] 张静, 刘畅, 华成舸. 妊娠期患者口腔诊疗进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(05): 340-344.
[4] 邢颖, 程石. 巨脾外科治疗现状与介入治疗序贯手术策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 253-258.
[5] 唐必英, 李钢. 治疗时机对动脉瘤性蛛网膜下腔出血患者预后的影响[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 213-219.
[6] 冯铭, 孙洪涛. 动脉瘤性蛛网膜下腔出血的颅内压监测与管理[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 248-253.
[7] 杨金朔, 吴桥伟, 王春雷, 史怀璋. 脑血管内支架成形术后再狭窄的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 174-179.
[8] 牟超鹏, 宗斌, 刘奕, 史美英, 徐杜娟, 冯春光. 经远端桡动脉与经常规桡动脉行急诊冠脉介入诊疗后穿刺部位血肿的对比[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 275-282.
[9] 陈芳, 王建英, 曹建用, 刘丽, 罗晓琴. 基于分析-设计-开发-实施-评价模式的叙事护理培训在产科预防性介入治疗中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 392-396.
[10] 李超迪, 刘娟芳, 闫肃, 秦胜东, 张镐哲, 常琼方, 韩新巍, 张建好. 血管性介入治疗在宫颈癌大出血患者中的临床疗效[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 217-220.
[11] 周宝林, 刘曦, 谌浩, 王金, 马雪琴. 温敏水凝胶在血管内栓塞治疗中的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 244-249.
[12] 郭方明, 赵明俐, 颜凡辉, 刘萌萌, 王阳, 赵英杰, 刘远航, 张艳芬, 詹景冬. 光学相干断层成像在急性心肌梗死冠状动脉分层斑块病变中的应用[J/OL]. 中华诊断学电子杂志, 2024, 12(02): 73-79.
[13] 周洪千, 张煜坤, 顾天舒, 胡苏涛, 姜超, 张雪, 张昊, 陶华岳, 刘行, 刘彤, 陈康寅. 既往出血性脑卒中患者行经皮冠脉介入治疗后不良事件的危险因素分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 323-329.
[14] 段丽娟, 蒋艳, 樊朝凤, 曹华. 颅内动脉瘤介入治疗术后不留置导尿管的效果及安全性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(02): 104-109.
[15] 许英, 彭采凤, 曾梁楠, 李倩茜, 杨昌美. 未破裂颅内动脉瘤介入治疗患者自我管理干预方案的构建[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(02): 164-170.
阅读次数
全文


摘要